PALbociclib CoLlaborative Adjuvant Study

PALbociclib CoLlaborative Adjuvant Study

Conditions: Breast Cancer
Interventions: Drug: Palbociclib; Drug: Standard Adjuvant Endocrine Therapy
Sponsors: Alliance Foundation Trials, LLC.; Austrian Breast & Colorectal Cancer Study Group; NSABP Foundation Inc; PrECOG, LLC.; Breast International Group; Pfizer
Active, not **RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

January 25, 2024Comments OffClinicalTrials.gov | Endocrinology Clinical Trials | Endocrinology Studies | US National Library of Medicine
Comments